chartexchange

MXCT
MaxCyte, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:49 PM EDT
1.07USD-2.283%(-0.02)228,079
After-hoursOct 2, 2026 4:20:30 PM EDT
1.09USD+1.869%(+0.02)
Loading…
Loading…
110.95M
Healthcare
Medical Devices
HQ
Rockville, MD, USA
Previous Close
$1.09
Beta
1.68
52-Week High
$1.87 2025-10-16
52-Week Low
$0.64 2026-02-17
SMA 50
$1.21
SMA 200
$1.08
Avg. Vol 10D
343,042
Avg. Vol 30D
400,801
Avg. Vol 90D
929,030
Relative Vol
0.57
103.21M
97.63M
0.3400%
2,600,000
3,248
Nov 11, 2026 (37d)
MXCT Profile

MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.

MXCT Performance
PeriodPriceDateChangeBeta
1W1.162026-09-28-7.33%-0.116
1M1.282026-09-04-16.02%0.959
3M1.272026-07-06-15.35%2.140
6M0.712026-04-06+50.54%2.126
1Y1.652025-10-06-34.85%1.675
2Y3.672024-10-04-70.71%—
5Y11.162021-10-05-90.37%1.437
MXCT Stock Summary

MaxCyte, Inc. Common Stock (NASDAQ:MXCT) stock price today is $1.08, and today's volume is 228,112. MXCT is down 1.376% today. The 30 day average volume is 400,801. MXCT market cap is $110.95M with 103.21M shares outstanding.